Transcription factor AP-2beta in development, differentiation and tumorigenesis

Area of Science:

• Developmental Biology
• Cancer Biology
• Genetics

Background:

• The AP-2 family has five transcription factors, with AP-2beta (TFAP2B) identified in 1995.
• TFAP2B is vital for ectodermal, neuroectodermal, and mesodermal tissue development.
• TFAP2B mutations cause Char syndrome, affecting facial features, heart development, and digit anatomy.

Purpose of the Study:

• To review the multifaceted roles of AP-2beta (TFAP2B) in organogenesis, cellular differentiation, and tumorigenesis.
• To highlight the significance of TFAP2B in both normal development and disease states.
• To consolidate current knowledge on TFAP2B's involvement in human health and disease.

Main Methods:

• Literature review of studies on TFAP2B function.
• Analysis of TFAP2B's role in genetic disorders and various cancer types.
• Examination of TFAP2B's impact on cell proliferation and patient prognosis.

Main Results:

• TFAP2B is implicated in tissue development and linked to Char syndrome and personality traits.
• In oncology, TFAP2B is a diagnostic marker for alveolar rhabdomyosarcoma and influences neuroblastoma differentiation.
• TFAP2B is associated with lobular breast cancer, affecting proliferation and patient outcomes.

Conclusions:

• TFAP2B is a key regulator in development and differentiation.
• TFAP2B has significant implications in various human pathologies, including cancer.
• Further research into TFAP2B's functions can inform therapeutic strategies.